Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Experimental and Therapeutic Medicine|September 20, 2021
Role of protein phosphatase 2A in kidney disease (Review)Lishi Shao, Yiqun Ma, Qixiang Fang, et al.
Experimental and Therapeutic Medicine|January 2, 2023
Identification of ferroptosis‑associated genes in chronic kidney diseaseLishi Shao, Qixiang Fang, Chaofei Ba, et al.
International Journal of Biological Macromolecules|January 25, 2026
Targeting the WWP2-ASPP2 axis overcomes cisplatin resistance by inhibiting the mevalonate pathway in TP53-mutant bladder cancerQixiang Fang, Chengyu You, Xi Xiao, et al.
Protein and Peptide Letters|September 8, 2025
Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic TargetingQixiang Fang, Chengyu You, Xi Xiao, et al.
Journal of Receptor and Signal Transduction Research|March 8, 2023
Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the ratsLishi Shao, Qixiang Fang, Chen Shi, et al.
Pageof 2